HOME >> MEDICINE >> NEWS
Breakthrough New Therapy Uses Antibody-Targeted Chemotherapy To Fight Leukemia

Scientists presented promising data today at the 35th Annual Meeting of the American Society of Clinical Oncology (ASCO) on the use of a pioneering drug technology known as "antibody-targeted chemotherapy" to fight acute myelogenous leukemia (AML) - a virulent and often fatal form of cancer. The experimental agent, CMA-676, induces remission in a significant proportion of patients with few serious side effects. CMA-676 represents the first successful application of antibody-targeted chemotherapy.

AML is an aggressive, life-threatening disease in which certain white blood cells become cancerous and rapidly replace normal bone marrow and blood cells. AML is among the most serious forms of adult leukemia, with a relatively high fatality rate. Most patients require intensive chemotherapy to achieve complete remission, and some also must undergo bone marrow transplants. Up to half of patients with AML, even after such intensive treatment, have residual leukemic cells or experience a relapse.

Because current chemotherapy drugs to treat AML are non-specific - destroying good as well as bad cells - patients receiving standard chemotherapy tend to become very sick. Researchers at the Fred Hutchinson Cancer Research Center, in collaboration with scientists from thirteen leading leukemia centers, including University of Chicago Medical Center, MD Anderson Cancer Center, and the University of Pennsylvania Cancer Center, are working with Wyeth-Ayerst Research and Celltech PLC to study CMA-676, an antibody-drug conjugate that delivers treatment directly to the leukemia cells.

The specificity of the conjugate lies in the antibody, which recognizes a cell-surface molecule that is abundant on AML cells. Importantly, however, the cell surface molecule is absent from normal blood stem cells, the seeds from which normal blood and immune cells originate. Specially engineered to carry a novel and extremely potent chemotherapy agent known as calicheamic
'"/>

Contact: Susan Edmonds
sedmonds@fhcrc.org
206-667-2896
Fred Hutchinson Cancer Research Center
16-May-1999


Page: 1 2

Related medicine news :

1. Breakthrough in medical research: New chemotherapy gives hope to brain tumour patients
2. Breakthrough therapies treat Crohns disease
3. Breakthrough cancer treatment Avastin receives first approval in the US
4. Breakthroughs in research may bring hope to 1.5 million Americans suffering from peanut allergy
5. Breakthrough in hormonal breast cancer therapy
6. Breakthrough! UNC scientists research promises improved X-ray machines using carbon nanotubes
7. Breakthrough pain in cancer associated with need for increased medical services, higher medical costs
8. Simple test predicts ability to grow new blood vessels: Breakthrough in battle against heart disease, diabetes, cancer
9. Low-Tech Treatment Proves A Life-Saver In Research Breakthrough
10. Breakthrough? Study Finds Dopamine Cannot Be Source Of Pleasure In Brain
11. Hunter College Biologist Marie Filbin Identifies Mechanism That Blocks All Inhibitors Of Nerve Regeneration; Breakthrough Reported In Neuron Magazine

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:9/11/2019)... ... , ... Ahipoki is excited to announce a new vegan and gluten free ... pescatarians and poke bowl fans alike. Ahimi is made of five simple ingredients ... similar to tuna, Ahipoki customers will now have a vegan option when ...
(Date:9/11/2019)... ... September 10, 2019 , ... ... problems facing the ever-changing corporate landscape, Mediaplanet today announces the launch of ... With topics ranging from the importance of candid one-on-one conversations, ideas for ...
(Date:9/9/2019)... ... September 09, 2019 , ... Sharon, ... attended the American Association of Dental Office Management (AADOM) Annual Conference. This year, ... Year (PAOY) award. This is Sharon’s third nomination in a row. The entire ...
(Date:9/8/2019)... DELAND, Fla. (PRWEB) , ... September 09, 2019 , ... ... Best Colleges list of Best Regional Universities – South, released today. In addition, Stetson ... Best Value Schools, No. 11; Most Innovative Universities, No. 14; Campus Ethnic Diversity, No. ...
(Date:9/8/2019)... ... September 06, 2019 , ... ProRehab Louisville has ... injury experts for rehabilitation to young Louisville athletes. , Building off of a ... and fitness programs, the expert physical therapists at ProRehab will be ensuring that ...
Breaking Medicine News(10 mins):
(Date:9/11/2019)... ... September 11, 2019 , ... LifePod® ... innovator HomeThrive has selected LifePod’s voice-first service for rollout to an initial 100 ... over the age of 50, demand has steadily increased for solutions that both ...
(Date:9/11/2019)... ... September 11, 2019 , ... Genedata, the leading ... globally operating Finnish pharmaceutical company, has licensed Genedata Biologics® to support their R&D ... , “As part of our strategy to expand our biopharmaceutical R&D operations, ...
(Date:9/11/2019)... , ... September 11, 2019 , ... ... for real time delivery of medical spa treatment approvals, will be speaking on ... at Telehealth Secrets Conference October 2-4, 2019 in Silicon Valley. , Gazaui brings ...
Breaking Medicine Technology:
Cached News: